Anthropic's $400M Bio Buy and Flagship's AWS Deal | AI Drug Discovery Weekly — April 6
This week brought some serious market moves that’ll reshape how we think about AI in drug discovery.
Sprintome - AI + Drug Discovery
Accelerated Drug Discovery | Your front-row seat to the future of medicine
Live Last read · last published · next check
Latest posts
Insilico’s $2.75B Lilly Deal, Every Cure’s $190M Raise & MIT’s VibeGen Redefines Protein Design | AI Drug Discovery Weekly — March 30
This week delivered the biggest AI drug discovery deal we’ve ever seen, plus a flood of new partnerships that show how quickly the field is maturing.
AlphaFold Expands to Protein Complexes, Merck Open-Sources 11M-Molecule Model & Multi-Agent AI Enters Drug Discovery | AI Drug Discovery Weekly — March 23
Google’s AlphaFold took a major leap beyond individual proteins, while Merck opened up an 11M-molecule foundation model that could become the new standard for lead optimization.
A Man Used AI to Create a Cancer Vaccine for His Dog, Waiv Spins Out of Owkin With $33M & OpenFold3 Goes Fully Open | AI Drug Discovery Weekly — March 15
A tech founder reportedly used AI tools including ChatGPT and AlphaFold to help design a personalized cancer vaccine for his dying dog. OpenFold3. Biomedical OpenClaw. 4 major partnerships. And more.
Generate’s $425M IPO and a New 2.6B-Parameter Model | Sprintome Weekly Roundup — March 9
The weekly briefing on AI-driven drug discovery
A 2.6B Parameter Model Just Beat Models 10× Larger in Drug Discovery
For the past two years, pharmaceutical AI has followed the same script as the rest of machine learning.
OpenClaw and the Coming Shift in AIxBio
If you have seen the recent OpenClaw and “clawbot” wave online, this is article is about that.
The Evolution of AI in Scientific Discovery: A New Era in the Life Sciences
AI is becoming a powerful partner in scientific research, especially in bio and medicine.
⚡️Boltz‑2: The Co‑Folding Model That Actually Predicts Binding Affinity
1,000× faster and 10,000× less expensive than traditional methods. Boltz-2 delivers FEP-level binding affinity in 18 seconds... And fully open-source thanks to MIT and Recursion.
The Protein Language Model: Bigger = Better?
An Intro to Protein Language Models (PLMs) 🧬 + Scaling Laws through the lens of ProGen3: architecture, protein generation/viability, alignment. (In English)